Cargando…
COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
Since its outbreak in China in December 2019 a novel Coronavirus, named SARS-CoV-2, has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 disease, leading the World Health Organization to declare a pandemic emergency in March 2020. Up to now, no specific therapy agains...
Autores principales: | Bartoli, Alessandra, Gabrielli, Filippo, Alicandro, Tatiana, Nascimbeni, Fabio, Andreone, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781413/ https://www.ncbi.nlm.nih.gov/pubmed/33398609 http://dx.doi.org/10.1007/s11739-020-02569-9 |
Ejemplares similares
-
Treatment options in obstructive sleep apnea
por: Gambino, Francesco, et al.
Publicado: (2022) -
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
por: Crescioli, Giada, et al.
Publicado: (2020) -
Treatments for HBV: A Glimpse into the Future
por: Bartoli, Alessandra, et al.
Publicado: (2021) -
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey
por: Tomaselli, Venera, et al.
Publicado: (2022) -
Diagnosis and management of leukocytoclastic vasculitis
por: Fraticelli, Paolo, et al.
Publicado: (2021)